Singapore Infant Formula Ingredients Market Size & Outlook, 2026-2034

Singapore Infant Formula Ingredients Market Insights

As highlighted in Deep Market Insights analysis, the Singapore Infant Formula Ingredients Market, worth USD 59.96 Million in 2025, is forecasted to achieve USD 87.79 Million by 2034.
The Singapore market is anticipated to grow at a CAGR of 4.33% during the period 2026–2034.
By 2025, Proteins represented the largest share of the By Type market size.
Vitamins & minerals is expected to remain the key growth driver within By Type, registering the fastest CAGR during the forecast period.

Singapore accounted for 0.35% of the global Infant Formula Ingredients Market size in 2025.
By 2034, United States is expected to remain the top global market in terms of size.
Within Asia Pacific, China is forecasted to dominate the regional Infant Formula Ingredients Market size by 2034.
India will be the fastest-growing market in Asia Pacific, projected to achieve USD 784 Million by 2034.

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 59.96 Million
Market Size In 2034	USD 87.79 Million
Largest segment	Proteins
Units	Revenue in USD Million
CAGR	4.33% (2026-2034)
Segmnetation Covered
By Type	Proteins Carbohydrates Fats & oils Vitamins & minerals
By Source	Dairy-based Plant-based Synthetic Animal-based
By Application	Infant milk formula Follow-on formula Specialty formula Medical nutrition
By Form	Powder Liquid Concentrate Blends
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

By Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Proteins	XX.x	XX.x	XX.x	29.64	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Carbohydrates	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Fats & oils	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Vitamins & minerals	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Source	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Dairy-based	XX.x	XX.x	XX.x	26.24	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Plant-based	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Synthetic	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Animal-based	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Infant milk formula	XX.x	XX.x	XX.x	24.16	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Follow-on formula	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Specialty formula	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Medical nutrition	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Form	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Powder	XX.x	XX.x	XX.x	24.17	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Liquid	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Concentrate	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Blends	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x